T
23.75
1.01 (4.42%)
| Penutupan Terdahulu | 22.74 |
| Jumlah Dagangan | 2,187,458 |
| Harga / Jualan (P/S) | 54.04 |
| Harga / Buku (P/B) | 3.93 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -788.76% |
| EPS Cair (TTM) | -1.20 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -16.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 22.16% |
| Nisbah Semasa (MRQ) | 6.26 |
| Aliran Tunai Operasi (OCF TTM) | -135.34 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -67.25 M |
| Pulangan Atas Aset (ROA TTM) | -26.79% |
| Pulangan Atas Ekuiti (ROE TTM) | -61.35% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Tango Therapeutics, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Nilai 35% | 0.0 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | 0.0 |
| Masa 35% | -0.7 |
| AI Technical info | NA |
| Osilator Teknikal info | -0.5 |
| Purata Bergerak Teknikal info | -1.0 |
| Wang Pintar 30% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | 0.0 |
| Persekitaran | ×1.21 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -22.5% |
| Persetujuan Tonggak | ×1.00 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | 0.7 |
| Skor Akhir | -0.30 |
|
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 12.59% |
| % Dimiliki oleh Institusi | 97.41% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Trv Gp Iv, Llc | 30 Jun 2026 | 6,374,574 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| CRYSTAL ADAM | - | 21.76 | -5,000 | -108,800 |
| NEWCOMB JESSICA | - | 21.76 | -7,031 | -152,995 |
| Jumlah Keseluruhan Kuantiti Bersih | -12,031 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -261,795 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 21.76 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| NEWCOMB JESSICA | Pegawai | 02 Nov 2026 | Jual automatik (-) | 7,031 | 21.76 | 152,995 |
| CRYSTAL ADAM | Pegawai | 02 Nov 2026 | Jual automatik (-) | 5,000 | 21.76 | 108,800 |
| CRYSTAL ADAM | Pegawai | 02 Nov 2026 | Pelaksanaan pilihan | 5,000 | - | - |
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |